Exact Sciences Corp chart

Last update: 2022-12-30
Key statistics and financials
Revenue per share 11.45
Dividend & YieldN/A$ (N/A)
Beta 1.31
Market capitalization 7.32B
Operating cash flow -300.17M
ESG Scores unknown

Company description

Exact Sciences Corporation provides cancer screening and diagnostic test products in the United States and internationally. The company offers Cologuard, a non-invasive stool-based DNA screening test to detect DNA and hemoglobin biomarkers associated with colorectal cancer and pre-cancer. It also provides Oncotype DX, a gene expression tests for breast, prostate, and colon cancers; Oncotype Test, a tissue test delivering tumor profiling to aid therapy selection for patients with advanced, metastatic, refractory, or recurrent cancer; Oncotype DX AR-V7 Nucleus Detect Test, a liquid-based test for advanced stage prostate cancer; Oncomap ExTra, that provides a complete biological picture of certain refractory, rare, or aggressive cancers; and Covid-19 testing services. The company's pipeline products focus on enhancing the Cologuard test's performance characteristics and developing blood and other fluid-based tests. It has license agreements with MAYO Foundation for Medical Education and Research; and Hologic, Inc. Exact Sciences Corporation was incorporated in 1995 and is headquartered in Madison, Wisconsin.

Sector: Healthcare - Industry: Diagnostics & Research

Financial Ratios
Quick Ratio2.56
Working Capital-0.66
Return On Equity-0.18
Debt To Equity0.64
Fixed Asset Ratio0.34
Fixed Interest Cover-37

Financial data

Financial Statements

Cashflow Statement 2018-12-31 2019-12-31 2020-12-31 2021-12-31
Change To Liabilities 33.08M 3.47M 55.16M 169.8M
Total Cashflows From Investing Activities -782.3M -124.43M -702.04M -1.08B
Net Borrowings 920.67M 236.12M 974.24M -23.75M
Total Cash From Financing Activities 934.14M 253.18M 1.88B 8.47M
Change To Operating Activities -3.97M -10.35M 33.4M -74.62M
Issuance Of Stock 11.53M 17.18M 907.13M 37.51M
Net Income -175.15M -213.09M -823.61M -595.62M
Change In Cash 82.94M 17.1M 1.31B -1.18B
Effect Of Exchange Rate 36k 23k 23k 23k
Total Cash From Operating Activities -68.94M -111.66M 136.48M -102.24M
Depreciation 23.08M 50.25M 163.36M 180.35M
Change To Account Receivables -17.29M -27.63M -100.53M 25.15M
Other Cashflows From Financing Activities 1.95M -123k -1.75M -5.29M
Change To Netincome 55.47M 106.5M 837.45M 195.25M
Capital Expenditures -150.09M -172.65M -65.08M -135.77M

Income Statement 2018-12-31 2019-12-31 2020-12-31 2021-12-31
Research Development 67.28M 139.69M 554.05M 385.65M
Income Before Tax -175.06M -406.44M -829.06M -842.51M
Net Income -175.15M -213.09M -823.61M -595.62M
Selling General Administrative 427.46M 737.63M 1.07B 1.52B
Gross Profit 337.82M 659.58M 1.14B 1.31B
Ebit -159.47M -233.78M -582.02M -688.51M
Operating Income -159.47M -233.78M -582.02M -688.51M
Interest Expense -36.79M -199.19M -67.94M -18.61M
Income Tax Expense 92k -193.35M -5.46M -246.88M
Total Revenue 454.46M 876.29M 1.49B 1.77B
Cost Of Revenue 116.64M 216.72M 354.32M 458.76M
Total Other Income ExpenseNet -15.59M -172.66M -247.04M -154M
Net Income From Continuing Ops -175.15M -213.09M -823.61M -595.62M
Net Income Applicable To Common Shares -175.15M -213.09M -823.61M -595.62M

Balance Sheet Statement 2018-12-31 2019-12-31 2020-12-31 2021-12-31
Total Liabilities 843.08M 1.22B 2.69B 3.3B
Total Stockholder Equity 680.94M 2.29B 2.24B 3.39B
Other Current Liabilities 41.45M 21.92M 40.2M 50.65M
Total Assets 1.52B 3.51B 4.93B 6.68B
Common Stock 1.23M 1.48M 1.59M 1.74M
Other Current Assets
Retained Earnings -1.04B -1.12B -2.05B -2.64B
Treasury Stock -1.42M -100k 526k -1.44M
Cash 160.43M 177.25M 1.49B 315.47M
Total Current Liabilities 136.17M 236.49M 633.1M 517.07M
Other Stockholder Equity -1.42M -100k 526k -1.44M
Property, Plant, and Equipment 245.26M 582.07M 596.53M 762.07M
Total Current Assets 1.23B 553.94M 2.2B 1.43B
Net Tangible Assets 634.66M -58.69M 150.76M -1.05B
Net Receivables 45.33M 130.36M 233.19M 219.84M
Accounts Payable 28.14M 25.97M 35.71M 67.83M


Insider Transactions

Here are the insider transactions of stock shares related to Exact Sciences Corp:

Filer Name Transaction Text Ownership Date Filer Relation Shares
CUNNINGHAM EVERETTSale at price 31.37 per share.D2022-10-12Officer16.87k
CUNNINGHAM EVERETTD2022-10-11Officer35.01k
BARANICK BRIANSale at price 47.12 per share.D2022-08-05Officer984
BARANICK BRIAND2022-08-04Officer2.71k
ZANOTTI KATHERINE SSale at price 45.14 per share.D2022-07-26Director4.61k
ZANOTTI KATHERINE SConversion of Exercise of derivative security at price 10.18 per share.D2022-07-26Director4.61k
CONROY KEVIN TSale at price 40.75 per share.D2022-07-01Chief Executive Officer7
ZANOTTI KATHERINE SSale at price 40.13 per share.D2022-06-30Director1.09k
LEVANGIE DANIEL JStock Award(Grant) at price 0.00 per share.D2022-06-09Director5.61k
ZANOTTI KATHERINE SStock Award(Grant) at price 0.00 per share.D2022-06-09Director5.61k
CLANCY PAUL J.Stock Award(Grant) at price 0.00 per share.D2022-06-09Director5.61k
LEWIS-HALL FREDA CStock Award(Grant) at price 0.00 per share.D2022-06-09Director5.61k
DOYLE JAMES EDWARDStock Award(Grant) at price 0.00 per share.D2022-06-09Director5.61k
PETROVIC SHACEYStock Award(Grant) at price 0.00 per share.D2022-06-09Director5.61k
SEBELIUS KATHLEENStock Award(Grant) at price 0.00 per share.D2022-06-09Director7.52k
JACQUET PIERREStock Award(Grant) at price 0.00 per share.D2022-06-09Director7.24k
DOYLE JAMES EDWARDConversion of Exercise of derivative security at price 16.52 per share.D2022-06-07Director3k
CONROY KEVIN TStock Award(Grant) at price 47.41 per share.D2022-05-02Chief Executive Officer328
CUNNINGHAM EVERETTStock Award(Grant) at price 47.41 per share.D2022-05-02Officer520
CONROY KEVIN TConversion of Exercise of derivative security at price 5.70 - 44.37 per share.D2022-03-17Chief Executive Officer236.62k
DOYLE JAMES EDWARDConversion of Exercise of derivative security at price 16.52 per share.D2022-03-17Director10k
COWARD DAVID SCOTTSale at price 76.69 per share.D2022-03-01Officer3.91k
CONROY KEVIN TSale at price 76.69 per share.D2022-03-01Chief Executive Officer14.3k
ELLIOTT JEFFREY THOMASSale at price 76.69 per share.D2022-03-01Chief Financial Officer4.05k
CONDELLA SARAHSale at price 76.69 per share.D2022-03-01Officer2.82k
COWARD DAVID SCOTTD2022-02-28Officer8.29k
CONROY KEVIN TD2022-02-28Chief Executive Officer29.89k
ELLIOTT JEFFREY THOMASD2022-02-28Chief Financial Officer8.46k
CONDELLA SARAHD2022-02-28Officer5.88k
CONDELLA SARAHSale at price 74.05 - 75.15 per share.D2022-02-25Officer5.48k
COWARD DAVID SCOTTSale at price 70.10 per share.D2022-02-24Officer5.82k
ORVILLE JACOB ASale at price 70.10 per share.D2022-02-24Officer4.72k
CONROY KEVIN TSale at price 70.10 per share.D2022-02-24Chief Executive Officer27.13k
ELLIOTT JEFFREY THOMASSale at price 70.10 per share.D2022-02-24Chief Financial Officer5.9k
CONDELLA SARAHSale at price 70.10 per share.D2022-02-24Officer4.72k
COWARD DAVID SCOTTSale at price 69.05 per share.D2022-02-23Officer1.11k
COWARD DAVID SCOTTD2022-02-23Officer12.75k
ORVILLE JACOB ASale at price 69.05 per share.D2022-02-23Officer1.12k
ORVILLE JACOB AD2022-02-23Officer10.2k
CONROY KEVIN TSale at price 69.05 per share.D2022-02-23Chief Executive Officer5.19k
CONROY KEVIN TD2022-02-23Chief Executive Officer58.64k
ELLIOTT JEFFREY THOMASSale at price 69.05 per share.D2022-02-23Chief Financial Officer1.56k
ELLIOTT JEFFREY THOMASD2022-02-23Chief Financial Officer12.75k
CONDELLA SARAHSale at price 69.05 per share.D2022-02-23Officer1.12k
CONDELLA SARAHD2022-02-23Officer10.2k
COWARD DAVID SCOTTD2022-02-22Officer2.25k
ORVILLE JACOB ASale at price 72.72 per share.D2022-02-22Officer1.75k
ORVILLE JACOB AD2022-02-22Officer2.25k
CONROY KEVIN TD2022-02-22Chief Executive Officer10.37k
ELLIOTT JEFFREY THOMASD2022-02-22Chief Financial Officer3.11k
CONDELLA SARAHD2022-02-22Officer2.25k

Insider transaction explanations

Insider buying is the legal purchase of shares by a senior executive or director of a company. "Filer Name" corresponds to the name of the stock buyer or seller. "Transaction Text" describes the transaction. "Ownership" gives information about the transaction type. "Date" is the reported transaction date. "Filer Relation" gives the role of the insider in the company. "Shares" is the value of the transaction. You will find the complete description of the General Transaction Codes on the SEC dedicated page


Investment strategy backtesting

These are the result of three automatic investment systems applied to Exact Sciences Corp. You will find the performance of an systematic investment system, a momentum strategy, and a buy the dip trading strategy.


Systematic investment results on Exact Sciences Corp

Here is the result of two systematic investment strategies applied to Exact Sciences Corp. The first strategy automatically buys the first day of the month, and the second strategy buys the fifteenth day of the month.

Systematic investment equity curve on Exact Sciences Corp

The following chart shows the equity curve of the two systematic investment strategies applied to Exact Sciences Corp:

Exact Sciences Corp automated entries

The systematic investment strategy that buys the first day of the month would give a performance of 10.26% on the backtest period.

Performance at glance

Performance

10.26 %

Latent gain

178.01 $

Invested capital

1734.91 $

Annualized return

2.5 %
Build your Trading System
Automated Trading using Prorealtime ebook

Momentum strategy results on Exact Sciences Corp

This is the result of two momentum investment strategies applied to Exact Sciences Corp. The first strategy uses a momentum signal calculated on one quarter, and the second uses a momentum signal calculated on two quarters.

Momentum entry openings on Exact Sciences Corp

The following chart shows all the entries opened by the momentum investment system on Exact Sciences Corp:

Exact Sciences Corp momentum entries
  • The first momentum investment strategy would give 32.59% of return on Exact Sciences Corp. That represents 1732.45$ of latent gain with 5315.15$ of employed capital.
  • The second momentum investment strategy would give 35.28% of return on Exact Sciences Corp. That represents 1076.49$ of latent gain with 3051.39$ of employed capital.
Performance at glance (1Q Momentum)

Performance

32.59 %

Latent gain

1732.45 $

Invested capital

5315.15 $

Annualized return

4.84 %
Performance at glance (2Q Momentum)

Performance

35.28 %

Latent gain

1076.49 $

Invested capital

3051.39 $

Annualized return

9.75 %

Momentum equity curve on Exact Sciences Corp

The following chart shows the equity curve of the two momentum strategies applied to Exact Sciences Corp:

Exact Sciences Corp momentum equity

Note: the dividends potentially given by Exact Sciences Corp are not integrated into the calculation of the equity curve neither the performance of the strategy. The integration of the dividends will be available soon.


Employed capital on Exact Sciences Corp

The following chart shows the employed capital evolution of the two momentum strategies on Exact Sciences Corp since the beginning:

Exact Sciences Corp

Note: the algorithm buys for a maximum of 250$ per entry. If the stock price is greater than 250$, the system buys only one stock per entry. The investment system stops automatically when the financial exposure reaches 10000$.


Buy the dip strategy result on Exact Sciences Corp

Buy the dip entry openings on Exact Sciences Corp

Exact Sciences Corp

The performance achieved by the robo-advisor on Exact Sciences Corp is 10.17%. That represents 157.98$ of latent gain with 1553.58$ of employed capital. The following chart shows Exact Sciences Corp stock price with all the entries opened by the automated investment system.

Note: The blue line represents the weekly stock price of Exact Sciences Corp, and the green triangles represent the entry openings. The artificall robo-advisor needs at least 100 weeks of trading history to work.

Performance at glance

Performance

10.17 %

Latent gain

157.98 $

Invested capital

1553.58 $

Annualized return

4.84 %

Equity curve of the strategy applied to Exact Sciences Corp

The following chart shows the result of the investment strategy applied to Exact Sciences Corp:

Exact Sciences Corp

Note: the dividends potentially given by Exact Sciences Corp are not integrated into the calculation of the equity curve neither the performance of the strategy. The integration of the dividends will be available soon.


Employed capital on Exact Sciences Corp

The following chart shows the employed capital evolution since the beginning of the investment strategy on Exact Sciences Corp:

Exact Sciences Corp

Note: the algorithm buys for a maximum of 250$ per entry. If the stock price is greater than 250$, the system buys only one stock per entry. The investment system stops automatically when the financial exposure reaches 10000$.


Investment strategies comparison on Exact Sciences Corp

In this section, I will compare the three previous investment strategies applied to Exact Sciences Corp.

Equity curve comparison on Exact Sciences Corp

The following chart shows the equity curve of the artificall advisor, the trend folowing and the automatic investment strategies:

Exact Sciences Corp investment strategy comparison

Employed capital comparison on Exact Sciences Corp

Exact Sciences Corp investment comparison

Performance comparison on Exact Sciences Corp

Strategy Latent Profit Growth Employed capital CAGR
Automatic investment 10.26% 178.01$ 1734.91$ 2.5%
Momentum 1 quarter 32.59% 1732.45$ 5315.15$ 8.44%
Momentum 2 quarters 35.28% 1076.49$ 3051.39$ 9.75%
Non-directional 10.17% 157.98$ 1553.58$ 4.84%
Annualized return comparison

Automatic investment

2.5 %

Momentum 1Q

9.75 %

Momentum 2Q

9.75 %

Non-directional

4.84 %

Correlated stocks

Here are the most positively and negatively correlated stocks with Exact Sciences Corp:

Note: The algorithm computes the probability of correlation between Exact Sciences Corp and the other stocks. There may be false positives or some missing correlated stocks. If the price of Exact Sciences Corp does not vary for 36 weeks, the correlation calculation result will be wrong.


Company information

Company name Exact Sciences Corp
Country United States
City Madison
Address 5505 Endeavor Lane
Phone 608 284 5700
Website www.exactsciences.com
FullTime employees 6420
Industry Diagnostics & Research
Sector Healthcare
Exchange XNAS
Ticker EXAS
Market www.nasdaq.com

Exact Sciences Corp ESG Scores

Environment scores

Environment ESG Factors Scores
Environment Score 0
Peer Environment Performance unknown
Environment Percentile unknown
Palm Oil unknown
Nuclear unknown
Fur Leather unknown
GMO unknown
Coal unknown
Pesticides unknown
Animal Testing unknown

Social scores

Social ESG Factors Scores
Social Score 0
Peer Social Performance unknown
Social Percentile unknown
Highest Controversy unknown
Peer Highest Controversy Performance unknown
Adult unknown
Gambling unknown
Alcoholic unknown
Tobacco unknown
Catholic unknown
Controversial Weapons unknown
Small Arms unknown
Military Contract unknown
Peer Count unknown

Related Controversy:


Governance scores

Governance ESG Factors Scores
Governance Score 0
Peer Governance Performance unknown
Governance Percentile unknown

ESG at glance
Total ESG Scores: unknown
Environment Score: 0
Social Score: 0
Governance Score: 0

ESG Performance: unknown

Peer Group: unknown

Peer Esg Score Performance: unknown

Rating Year: unknown

Rating Month: unknown

Max Age: unknown

Percentile: unknown